Klaus Veitinger's most recent trade in scPharmaceuticals Inc was a trade of 19,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
scPharmaceuticals Inc | Klaus Veitinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 19,750 | 19,750 | - | - | Stock Option (Right to Buy) | |
scPharmaceuticals Inc | Klaus Veitinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,300 | 17,300 | - | - | Stock Option (Right to Buy) | |
scPharmaceuticals Inc | Klaus Veitinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,300 | 16,300 | - | - | Stock Option (Right to Buy) | |
scPharmaceuticals Inc | Klaus Veitinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 16,300 | 16,300 | - | - | Stock Option (Right to Buy) | |
scPharmaceuticals Inc | Klaus Veitinger | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 6,124 | 6,124 | - | - | Stock Option (Right to Buy) |